PATENT CLAIM ANALYSIS

Application Number: 16285762
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "274000"]

Abstract:
There is provided a compound of formula (I) which is an inhibitor of the family of p38 mitogen-activated protein kinase enzymes, and to its use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and COPD.

Claim (Index 7):
A compound according to  claim 3 , wherein the compound of formula (I) as the anhydrous free base is in solid crystalline form having an X-ray powder diffraction pattern containing one, two, three, four, five, six, seven or all eight peaks selected from (\u00b10.2) 3.9, 6.1, 11.8, 14.3, 16.7, 18.3, 18.7 and 28.9 degrees 2-theta.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 99.0
- Lexical Diversity: 1.425
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14795957', '14349345', '15812425', '15925384', '15636730']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7909216193258355
- 35 USC 102 Novelty (BERT): 0.6373423451768249
- Combined Prediction Score: 0.7755636919109344
- Mean Citation Score: 452.28391400000015
- Max Citation Score: 575.10077
- Similarity Product: 563.7588469912612

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test